» Articles » PMID: 7011532

Characterization of a Murine Ovarian Reticulum Cell Sarcoma of Histiocytic Origin

Overview
Journal Cancer Res
Specialty Oncology
Date 1981 Apr 1
PMID 7011532
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

We have studied the M5076 tumor, a transplantable murine reticulum cell sarcoma that arose spontaneously in the ovary of a C57BL/6 mouse. This tumor displays functional and ultrastructural characteristics indicating that it is of macrophage origin. Cells from the M5076 tumor are phagocytic, form rosettes with sheep red blood cells, mediate antibody-dependent cellular cytotoxicity against 51Cr-labeled red blood cells, and display macrophage-like cytotoxicity against syngeneic tumor target cells but do not exhibit any natural killer cell activity. The tumor cells possess lysozyme, nonspecific esterase, and phosphatase activities comparable to that seen in rodent macrophages. Ultrastructural examination revealed phagocytic vacuoles and a lack of tight junctions typical of macrophage morphology. Karyotype analysis showed that M5076 tumor cells are hypodiploid with a high percentage (greater than 80%) of metacentric chromosomes that serve as an excellent marker for identification of these tumor cells.

Citing Articles

On the origin of cancer metastasis.

Seyfried T, Huysentruyt L Crit Rev Oncog. 2012; 18(1-2):43-73.

PMID: 23237552 PMC: 3597235. DOI: 10.1615/critrevoncog.v18.i1-2.40.


Perspectives on the mesenchymal origin of metastatic cancer.

Huysentruyt L, Seyfried T Cancer Metastasis Rev. 2010; 29(4):695-707.

PMID: 20839033 PMC: 2962789. DOI: 10.1007/s10555-010-9254-z.


DJ-927, a novel oral taxane, overcomes P-glycoprotein-mediated multidrug resistance in vitro and in vivo.

Shionoya M, Jimbo T, Kitagawa M, Soga T, Tohgo A Cancer Sci. 2003; 94(5):459-66.

PMID: 12824894 PMC: 11160250. DOI: 10.1111/j.1349-7006.2003.tb01465.x.


Membrane transport and antitumor activity of pirarubicin, and comparison with those of doxorubicin.

Sugiyama T, Sadzuka Y, Nagasawa K, Ohnishi N, Yokoyama T, Sonobe T Jpn J Cancer Res. 1999; 90(7):775-80.

PMID: 10470291 PMC: 5926135. DOI: 10.1111/j.1349-7006.1999.tb00814.x.


Human lymphotoxin mutein lacks hypotensive activity but has higher in vivo antitumor activity than lymphotoxin or tumor necrosis factor.

Taniyama M, Morita T, Yamagishi Y, Kato A, Bando C, Okawa N Proc Natl Acad Sci U S A. 1997; 94(7):3324-9.

PMID: 9096392 PMC: 20368. DOI: 10.1073/pnas.94.7.3324.